104 results
424B5
ARAV
Aravive Inc
28 Jun 23
Prospectus supplement for primary offering
6:01am
for distribution to stockholders after the payment of all of our debts and other liabilities and the satisfaction of any liquidation preference granted … defeasance;
additions to or changes in the provisions relating to satisfaction and discharge of the indenture;
additions to or changes in the provisions
8-K
EX-10.1
wfkhn
11 Apr 23
Aravive Appoints Carolina Petrini as Chief Commercial Officer
7:10am
8-K/A
EX-10.1
cc55w
28 Oct 22
Other Events
4:05pm
8-K
EX-10.1
f4bnfojked1r
26 Oct 22
Aravive Announces Approximately $41.5 Million Private Placement Financing
4:35pm
8-K
wxcb7d7y737mas9xqz5r
26 Oct 22
Aravive Announces Approximately $41.5 Million Private Placement Financing
4:35pm
8-K
EX-99.1
2rph5zk
26 Oct 22
Aravive Announces Approximately $41.5 Million Private Placement Financing
4:35pm
8-K
EX-4.1
geet2kmqq1 8t
26 Oct 22
Aravive Announces Approximately $41.5 Million Private Placement Financing
4:35pm
8-K
EX-4.2
swup0wws5pk1jhqd4gau
26 Oct 22
Aravive Announces Approximately $41.5 Million Private Placement Financing
4:35pm
8-K
EX-4.3
sta74h 070rdp8
26 Oct 22
Aravive Announces Approximately $41.5 Million Private Placement Financing
4:35pm
8-K
EX-10.1
q9of6w smq
5 Jul 22
Aravive Appoints Dr. Robert B. Geller as Chief Medical Officer
7:05am
8-K
EX-10.1
0bi3x
3 Jun 22
Aravive Appoints Rudy Howard as Chief Financial Officer
4:06pm
8-K
EX-4.1
5kne1y11iw
31 Mar 22
Aravive Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
6:26am
8-K
EX-4.2
p475vj4n73
31 Mar 22
Aravive Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
6:26am